The global 3D Bioprinting Market is expected to reach USD 2,687.8 million by 2027, according to a new report by Emergen Research.
The global 3D Bioprinting Market is expected to reach USD 2,687.8 million by 2027, according to a new report by Emergen Research. The 3D bioprinting market is expected to grow at a CAGR of 20.7% from 2020 to 2027. The increasing number of organ transplantation procedures and the rising demand for artificial organs are expected to drive the growth of the 3D bioprinting market during the forecast period.
In recent years, 3D bioprinting technology has emerged as a powerful tool for the regeneration of tissues and organs. 3D bioprinting technology is used to create three-dimensional (3D) structures by depositing biological cells in a layer-by-layer manner. This technology offers several advantages, such as the ability to create complex 3D structures, precise control over cell placement, and the ability to create functional tissues.
With the spread of the COVID-19, there is a sudden increase in the need for the vaccine and other medical treatments. The development of the vaccine and other medical treatments are dependent on the availability of raw materials, which in turn depends on the supply chain. 3D bioprinting offers an efficient and rapid way to produce these raw materials on-demand. This technology is being increasingly used in the healthcare sector for the manufacturing of human organs and tissues.
3D bioprinting technology is also being used for the development of personalized medicines. This is done by printing the patient’s own cells to create a custom-made medication. This technology is also being used to create artificial skin, which can be used to treat burns and other wounds. Also, 3D bioprinting is being used to create implants, such as artificial knees and hips.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/133
Technological advancement and the launch of new products are the key factors driving the growth of the 3D bioprinting market as it provides the ability to fabricate functional tissue models with high precision. 3D bioprinting technology helps in providing an efficient way to study various diseases and develop new therapeutic strategies for their treatment. Moreover, it also assists in reducing animal testing by providing an alternative model for preclinical drug testing.
Some Key Highlights from the Report
- The inkjet-based printing technology segment accounted for the largest market share in 2020. This technology is expected to grow at a high CAGR during the forecast period, owing to its ability to print three-dimensional (3D) structures with higher accuracy and resolution. On the other hand, the laser-based printing technology segment is projected to grow at the second-highest CAGR during the forecast period due to its ability to print complex 3D structures with high resolution.
- The pharmaceutical & biotech companies segment accounted for the largest share of the 3D bioprinting market in 2020. The growth of this segment can be attributed to the increasing demand for 3D bioprinted organs and tissues for drug discovery and preclinical testing applications. Also, the rising demand for 3D bioprinted organs and tissues for transplantation purposes is expected to drive the growth of this segment during the forecast period.
- The living cells segment is expected to grow at the highest CAGR during the forecast period. The growth of this segment can be attributed to the increasing use of 3D bioprinting in regenerative medicine and drug discovery applications. Also, bioprinting of living cells is gaining popularity as it can provide a more realistic in vivo environment for research.
- The North American region is expected to account for the largest share of the 3D bioprinting market during the forecast period. The large share of this regional segment can be attributed to increasing demand for 3D bioprinted organs and tissues, increasing investments by government and private companies in the field of 3D bioprinting and regenerative medicine. Also, the presence of a large number of key players in this region is another factor driving the growth of the 3D bioprinting market in North America.
- Key participants include Allevi Inc., Organovo Holdings, Inc., CELLINK, Aspect Biosystems Ltd., Cyfuse Biomedical K.K., EnvisionTEC GmbH, TeVido BioDevices, Poietis, Digilab, Inc., and Nano3D Biosciences, Inc, among others.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/3d-bioprinting-market
Emergen Research has segmented the global 3D Bioprinting Market on the basis of Technology, Material, Application, and region:
Technology Outlook (Revenue, USD Billion; 2017-2027)
- Laser-based
- Inkjet-based
- Syringe-based
- Magnetic Levitation
- Others
Material Outlook (Revenue, USD Billion; 2017-2027)
- Hydrogels
- Living Cells
- Extracellular Matrices
- Others
Application Outlook (Revenue, USD Billion; 2017-2027)
- Clinical Application ( Blood Vessels, Skin)
- Research Application (Regenerative Medicine, 3D Cell Culture, Drug research)
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/133
Explore More Reports Emergen Research:
Interventional Cardiology Devices Market
Electric Vehicle Fluids and Lubricants Market
Structural Insulated Panels Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-3d-bioprinting-market